Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q3 2019 Earnings

31JulConfirmed

Q4 2018

Q1 2019

Q2 2019

Q3 2019

-0.59

-0.52

-0.45

-0.38

Details

Expected EPS

-0.46

Actual EPS

-0.38

Surprise EPS

0.08

Surprise Percent

+17.39%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.38 per share for Q3 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.